Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase II data on AG-10 in ATTR cardiomyopathy support entry into phase III

Nov. 22, 2019

ALG-055009: a THR-beta agonist for treating NASH

Nov. 22, 2019

Positive preclinical data reported for leronlimab in humanized mouse model of NAFLD

Nov. 22, 2019

Pfizer initiates first-in-human study of PF-07038124

Nov. 22, 2019

First-in-human study of AZD-2693

Nov. 22, 2019

FDA clears IND application for phase I study of BP-1002

Nov. 22, 2019

European Commission approves Rhokiinsa

Nov. 22, 2019

Osteoclast precursor macrophages are potential RA therapeutic targets

Nov. 22, 2019

Recessive mutations in BSN identified as potential new cause of SRNS

Nov. 22, 2019

Phase I data reported for DNA vaccine GLS-6150 in patients with chronic HCV infection

Nov. 22, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...